We aimed to investigate two main polymorphisms in the 3' untranslated region (3'UTR) of the HLA-G gene [14 bp insertion/deletion (INS/DEL) and +3142 C > G] and to assess their impact on the soluble HLA-G (sHLA-G) production in patients with multiple sclerosis (MS). This study included 60 patients with relasping-remitting (RR) MS and 112 healthy donors (HD). Mutations were identified by PCR and PCR–RFLP, and serum sHLA-G quantification was performed by ELISA. For the 14 bp INS/DEL polymorphism, variants frequencies were similar in patients and controls, whereas a significant increased frequency of the +3142 G allele was found in MS patients compared to HD (63.4% vs 52.3%, p = 0.04; OR = 1.58, 95%CI = 1.003–2.48). In addition, an association was found between MS susceptibility and the haplotypes regrouping both studied polymorphisms. Indeed, the 14 bp DEL/ + 3142 G haplotype frequency was significantly increased in MS patients compared to HD (20.8% vs 12.5%, p = 0.04, OR = 1.84). On the other hand, no associations were detected between both polymorphisms and clinical parameters, except the lower age of disease onset (ADO) in patients with the +3142 C/C genotype. Moreover, our study doesn't show any significant variation of sHLA-G serum levels between patients and controls. Our findings showed that the +3142 C > G, but not the 14 bp INS/DEL, polymorphism may constitute a genetic susceptibility factor to MS in the Tunisian population. However, no association was found between the two polymorphisms and sHLA-G serum levels.
The association between functional HLA-G 14 bp insertion/deletion and +3142 C > G polymorphisms and susceptibility to multiple sclerosis
BORTOLOTTI, Daria;ROTOLA, Antonella;CASELLI, Elisabetta;DI LUCA, DarioPenultimo
;RIZZO, RobertaUltimo
2016
Abstract
We aimed to investigate two main polymorphisms in the 3' untranslated region (3'UTR) of the HLA-G gene [14 bp insertion/deletion (INS/DEL) and +3142 C > G] and to assess their impact on the soluble HLA-G (sHLA-G) production in patients with multiple sclerosis (MS). This study included 60 patients with relasping-remitting (RR) MS and 112 healthy donors (HD). Mutations were identified by PCR and PCR–RFLP, and serum sHLA-G quantification was performed by ELISA. For the 14 bp INS/DEL polymorphism, variants frequencies were similar in patients and controls, whereas a significant increased frequency of the +3142 G allele was found in MS patients compared to HD (63.4% vs 52.3%, p = 0.04; OR = 1.58, 95%CI = 1.003–2.48). In addition, an association was found between MS susceptibility and the haplotypes regrouping both studied polymorphisms. Indeed, the 14 bp DEL/ + 3142 G haplotype frequency was significantly increased in MS patients compared to HD (20.8% vs 12.5%, p = 0.04, OR = 1.84). On the other hand, no associations were detected between both polymorphisms and clinical parameters, except the lower age of disease onset (ADO) in patients with the +3142 C/C genotype. Moreover, our study doesn't show any significant variation of sHLA-G serum levels between patients and controls. Our findings showed that the +3142 C > G, but not the 14 bp INS/DEL, polymorphism may constitute a genetic susceptibility factor to MS in the Tunisian population. However, no association was found between the two polymorphisms and sHLA-G serum levels.File | Dimensione | Formato | |
---|---|---|---|
Immunology letters 2016.pdf
solo gestori archivio
Descrizione: Full text editoriale
Tipologia:
Full text (versione editoriale)
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
696.71 kB
Formato
Adobe PDF
|
696.71 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
j.imlet.2016.10.006.pdf
accesso aperto
Descrizione: Post-print
Tipologia:
Post-print
Licenza:
Creative commons
Dimensione
403.77 kB
Formato
Adobe PDF
|
403.77 kB | Adobe PDF | Visualizza/Apri |
I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.